Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints
Wave Life Sciences (NASDAQ:WVE), developer of RNA medicines for rare genetic diseases, closed Thursday at $6.20, down 49.59% for the session. The stock sank after disappointing higher-dose WVE-007...
Nasdaq News: Markets·11d ago